Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium

It has been recognized that molecular classifications will form the basis for neuropathological diagnostic work in the future. Consequently, in order to reach a diagnosis of Alzheimer's disease (AD), the presence of hyperphosphorylated tau (HP‐tau) and β‐amyloid protein in brain tissue must be...

Descripción completa

Detalles Bibliográficos
Autores principales: Alafuzoff, Irina, Arzberger, Thomas, Al‐Sarraj, Safa, Bodi, Istvan, Bogdanovic, Nenad, Braak, Heiko, Bugiani, Orso, Del‐Tredici, Kelly, Ferrer, Isidro, Gelpi, Ellen, Giaccone, Giorgio, Graeber, Manuel B., Ince, Paul, Kamphorst, Wouter, King, Andrew, Korkolopoulou, Penelope, Kovács, Gábor G., Larionov, Sergey, Meyronet, David, Monoranu, Camelia, Parchi, Piero, Patsouris, Efstratios, Roggendorf, Wolfgang, Seilhean, Danielle, Tagliavini, Fabrizio, Stadelmann, Christine, Streichenberger, Nathalie, Thal, Dietmar R., Wharton, Stephen B, Kretzschmar, Hans
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659377/
https://www.ncbi.nlm.nih.gov/pubmed/18371174
http://dx.doi.org/10.1111/j.1750-3639.2008.00147.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2659377/
https://www.ncbi.nlm.nih.gov/pubmed/18371174
http://dx.doi.org/10.1111/j.1750-3639.2008.00147.x

Ejemplares similares